Melanoma Trial, Recruiting (NCT06666790)

Melanoma Trial, Recruiting NCT06666790 Sponsor: DermaSensor, Inc. Condition: Melanoma

Printed from Voxsanity (voxsanity.com.au) — NCT06666790 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Melanoma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a man or woman of any ethnic background, aged 40 or older
You have a skin spot or mole that a doctor suspects could be melanoma (a type of skin cancer)
You are willing and able to read, understand, and sign a consent form agreeing to take part

Who may not be able to join:

The skin spot is in a place the scanning device cannot reach, such as inside the ear or under a nail
The skin spot is on an area affected by conditions like psoriasis, eczema, or acne, which could interfere with the device being placed correctly
The skin spot is larger than 15mm (about the size of a small pea) at its widest point
The area of the skin spot that would be scanned is smaller than 2.5mm, meaning the device tip cannot fit within its borders
The skin spot has no clear, unbroken area of at least 2.5mm due to open sores, broken skin, or fluid such as blood
The skin spot is covered by a crust or scale that cannot be gently cleared to reveal at least 2.5mm of clean, intact skin
The skin spot is blocked by something that cannot be removed without breaking the skin, such as a tattoo or splinter
The skin spot has not been fully cleaned of oils, makeup, sunscreen, powders, markings, or staining products (such as iodine)
The skin spot is on the palms of the hands or soles of the feet
The skin spot is within 10mm (about 1 centimetre) of the eye
The skin spot is on or near a scar, a previously biopsied area, or anywhere that has had surgery before
The skin spot is on a mucous membrane, such as the genitals or lips
The skin spot is on skin that is currently sunburned
You have dementia or another condition — physical, neurological, or psychological — that would prevent you from signing a consent form or attending any required follow-up appointments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gary Slatko, MD, MBA, DermaSensor, Inc.

Phone: 508-776-0044

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06666790

Sponsor: DermaSensor, Inc.

Phase: Not Applicable

Status: Recruiting

Condition: Melanoma

Trial contact: 508-776-0044

More information: https://clinicaltrials.gov/study/NCT06666790

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a man or woman of any ethnic background, aged 40 or older
You have a skin spot or mole that a doctor suspects could be melanoma (a type of skin cancer)
You are willing and able to read, understand, and sign a consent form agreeing to take part

Who may not be able to join:

The skin spot is in a place the scanning device cannot reach, such as inside the ear or under a nail
The skin spot is on an area affected by conditions like psoriasis, eczema, or acne, which could interfere with the device being placed correctly
The skin spot is larger than 15mm (about the size of a small pea) at its widest point
The area of the skin spot that would be scanned is smaller than 2.5mm, meaning the device tip cannot fit within its borders
The skin spot has no clear, unbroken area of at least 2.5mm due to open sores, broken skin, or fluid such as blood
The skin spot is covered by a crust or scale that cannot be gently cleared to reveal at least 2.5mm of clean, intact skin
The skin spot is blocked by something that cannot be removed without breaking the skin, such as a tattoo or splinter
The skin spot has not been fully cleaned of oils, makeup, sunscreen, powders, markings, or staining products (such as iodine)
The skin spot is on the palms of the hands or soles of the feet
The skin spot is within 10mm (about 1 centimetre) of the eye
The skin spot is on or near a scar, a previously biopsied area, or anywhere that has had surgery before
The skin spot is on a mucous membrane, such as the genitals or lips
The skin spot is on skin that is currently sunburned
You have dementia or another condition — physical, neurological, or psychological — that would prevent you from signing a consent form or attending any required follow-up appointments

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

DermaSensor, Inc.

Registry

ClinicalTrials.gov

Start date

8 October 2024

Est. completion

11 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Device Sensitivity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov